For the quarter ending 2026-01-31, VNOV has $2,311,806 in assets. $457,975 in debts.
| Balance Sheets | 2026-01-31 | |||
|---|---|---|---|---|
| Cash | 1,168,904 | |||
| Accounts receivable | 1,004,442 | |||
| Advances to vendors | 0 | |||
| Inventories | 130,436 | |||
| Other current assets | 8,024 | |||
| Total current assets | 2,311,806 | |||
| Total assets | 2,311,806 | |||
| Accounts payable | 108,978 | |||
| Accrued expenses and other current liabilities | 81,951 | |||
| Income tax payable | 267,046 | |||
| Total current liabilities | 457,975 | |||
| Total liabilities | 457,975 | |||
| Common stock, 0.001 par value 200,000,000 shares authorized 8,337,454 shares issued and outstanding | 8,337 | |||
| Additional paid-in capital | 1,029,646 | |||
| Shares to be issued 20,000 shares of common stock | 3,000 | |||
| Retained earnings | 812,848 | |||
| Total shareholders equity | 1,853,831 | |||
| Total liabilities and shareholders equity | 2,311,806 | |||
VitaNova Life Sciences Corp (VNOV)
VitaNova Life Sciences Corp (VNOV)